Funded Tech Companies
Praxis Precision Medicines
Researching who provided funding to Praxis Precision Medicines? Blackstone, Adage Capital Management and Ample Plus Fund joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Praxis Precision Medicines
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Bdwy. 16th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
Praxis (Nasdaq: PRAX) is a genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders. At Praxis we get things done. Praxis is the process of using a theory or something that you have learned in a practical way.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/15/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marcio Souza
Chief Financial Officer
Stuart Chaffee
Chief Medical Officer
Bernard Ravina
Chief Scientific Officer
Steven Petrou
Vice President
Karl Hansen
Vice President
Gabriel Martinez
Vice President
Rosa Tarng
Vice President
Marion Wittmann
Company Investors
- Blackstone
- Adage Capital Management
- Ample Plus Fund
- Novo Ventures
- venBio
- Point72 Ventures
- OCV Partners
- Vida Ventures
- Irving Investors
- Cormorant Asset Management
- Eventide Asset Management (Finny Kuruvilla)
- Surveyor Capital
- Verition Fund Management
- Qatar Investment Authority
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs